GHRS — GH Research Income Statement
0.000.00%
Last trade - 00:00- $706.50m
- $557.80m
- 40
- 26
- 96
- 54
Annual income statement for GH Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.446 | 15.1 | 30.6 | 41.2 | 50.3 |
| Operating Profit | -0.446 | -15.1 | -30.6 | -41.2 | -50.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.446 | -9.2 | -22.5 | -35.6 | -39 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.446 | -9.2 | -22.5 | -35.6 | -39 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.446 | -9.2 | -22.5 | -35.6 | -39 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.446 | -9.2 | -22.5 | -35.6 | -39 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.009 | -0.211 | -0.432 | -0.684 | -0.749 |
| Dividends per Share |